Every year, 15,000 – 20,000 Americans sustain a spinal cord injury (SCI). Another 200,000 – 500,000 are living in the chronic stages of SCI every day. Loss of movement and sensation, persistent pain, and depression are common. Could stem cells play a role in finding a cure? Dr. Mark Tuszynski shares his work using neural stem cells to build bridges after an SCI – forming new relays across injury sites in the hopes of restoring limb function and feeling. Bob Yant, who suffered an SCI in 1981, joins Tuszynski to express the need for further research in the field of regenerative medicine and to share his story of living with and SCI.
UCSF has a long history of pioneering biomedical research and a bold vision for advancing science and seeking new ways to improve health care delivery nationwide. But, what does that actually mean in the near future and beyond?
This new series, part of the popular Mini Medical School for the Public, takes you inside the work of UCSF scientists to learn what the next decade may bring to the world of medicine. Hailing from a wide spectrum of disciplines, each explores a different topic that has the potential to impact the future of healthcare.
UCSF was the only medical school to be ranked in the top five in the nation in both research and primary care by US News and World Report, ranking fifth in biomedical research and third in primary care education. UCSF was also the only medical school ranked in the top five in all eight of the specialty areas covered by the survey in 2019.
Browse more programs in Next: UCSF Scientists Outline What’s To Come .
This series presented by leading clinicians and researchers from the UCSF Memory and Aging Center provides in-depth review of the neurodegenerative diseases of the brain, focusing primarily on Alzheimer’s disease. You’ll learn about the diverse clinical manifestations of Alzheimer’s, stages of illness, and current state of science regarding diagnosis, treatment and management of Alzheimer’s and other related diseases.
Early diagnosis can help preserve daily functioning for some time, even though the underlying disease process cannot be stopped or reversed.
Browse more programs in Alzheimer’s Disease and Other Neurodegenerative Diseases of the Brain.
Check out highlights from this year’s conference addressing a variety of topics, including the impact of trauma and immigration on child development and people with intellectual and developmental disabilities.
Offering a unique update for primary care and subspecialty health care professionals and others who care for children, youth, and adults with developmental disabilities and complex health care needs, the conference covered a broad spectrum of developmental disabilities across the lifespan including autism spectrum disorders, mental health, genetic screening and diagnoses, and intervention and therapeutic consideration. Focus on special education, law enforcement, and policy from a variety of specialists adds to the content.
Presentations by expert faculty should be of interest to pediatricians, family physicians, nurse clinicians, psychologists, and internists who are involved in the healthcare of individuals with developmental disabilities, as well as to those in other health-related disciplines including health policy, epidemiology, psychiatry, school health, social work, and case management services.
While the conference is designed for health care professionals, families and individuals with developmental disabilities will also learn from the various represented disciplines. The conference was held at UCSF on March 14 and 15, 2019.
Browse more programs in Developmental Disabilities Update
Every 65 seconds, someone in the United States develops Alzheimer’s disease. What can be done to stem the tide of this devastating disease? Researchers are looking to our genes. “One of the goals of genetics is to try and come up with as strong a set of predictors as is possible. This has influenced the way in which more recent genetic research has been done,” says Douglas R. Galasko, MD. On this episode of “On Our Mind,” Dr. Galasko shares the different types of genetic influences on people’s risk of developing Alzheimer’s disease. He explains how these genes are being studied and what being a carrier of Alzheimer’s associated genes means.
For more information on Alzheimer’s disease, visit our archive.